Kaveh Rayani

Kaveh Rayani

Auto-generated profile, based on publicly available information

Kaveh Rayani

Simon Fraser University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2021 in Journal of General Physiology
Verified
Journal Article
Open access
PDF file
MGMohammad-Reza Ghovanloo
Mohammad-Reza Ghovanloo
KCKoushik Choudhury
Koushik Choudhury
TBTagore S. Bandaru
Tagore S. Bandaru
MFMohamed A. Fouda
Mohamed A. Fouda
KRKaveh Rayani
Kaveh Rayani
PRPeter Ruben
Peter Ruben
Cannabidiol (CBD) is the primary nonpsychotropic phytocannabinoid found in Cannabis sativa, which has been proposed to be therapeutic against many conditions, including muscle spasms. Among its putative targets are voltage-gated sodium channels (Navs), which have been implicated in many conditions. We investigated the effects of CBD on Nav1.4, the skeletal muscle Nav subtype. We explored direct effects, involving physical block of the Nav pore, as well as indirect effects, involving modulation of membrane elasticity that contributes to Nav inhibition. MD simulations revealed CBD’s localization inside the membrane and effects on bilayer properties. Nuclear magnetic resonance (NMR) confirmed these results, showing CBD localizing below membrane headgroups. To determine the functional implications of these findings, we used a gramicidin-based fluorescence assay to show that CBD alters membrane elasticity or thickness, which could alter Nav function through bilayer-mediated regulation. Site-directed mutagenesis in the vicinity of the Nav1.4 pore revealed that removing the local anesthetic binding site with F1586A reduces the block of INa by CBD. Altering the fenestrations in the bilayer-spanning domain with Nav1.4-WWWW blocked CBD access from the membrane into the Nav1.4 pore (as judged by MD). The stabilization of inactivation, however, persisted in WWWW, which we ascribe to CBD-induced changes in membrane elasticity. To investigate the potential therapeutic value of CBD against Nav1.4 channelopathies, we used a pathogenic Nav1.4 variant, P1158S, which causes myotonia and periodic paralysis. CBD reduces excitability in both wild-type and the P1158S variant. Our in vitro and in silico results suggest that CBD may have therapeutic value against Nav1.4 hyperexcitability.

1 January 2021 in Journal of Biological Chemistry
Verified
Journal Article
Open access
KRKaveh Rayani
Kaveh Rayani
JSJustin Seffernick
Justin Seffernick
ALAlison Yueh Li
Alison Yueh Li
JDJonathan P. Davis
Jonathan P. Davis
ASAnne Marie Spuches
Anne Marie Spuches
GTGlen Findlay Tibbits
Glen Findlay Tibbits
Cardiac muscle thin filaments are composed of actin, tropomyosin, and troponin that change conformation in response to Ca2+ binding, triggering muscle contraction. Human cardiac troponin C (cTnC) is the Ca2+-sensing component of the thin filament. It contains structural sites (III/IV) that bind both Ca2+ and Mg2+, and a regulatory site (II) that has been thought to bind only Ca2+. Binding of Ca2+ at this site initiates a series of conformational changes that culminate in force production. However, the mechanisms that underpin the regulation of binding at site II remain unclear. Here, we have quantified the interaction between site II and Ca2+/Mg2+ through Isothermal Titration Calorimetry and Thermodynamic Integration simulations. Direct and competitive binding titration with wild type N-terminal cTnC (N-cTnC) and full-length cTnC indicate that physiologically relevant concentrations of both Ca2+/ Mg2+ interacted with the same locus. Moreover, the D67A/D73A N-cTnC construct in which two coordinating residues within site II were removed was found to have significantly reduced affinity for both cations. In addition, 1 mM Mg2+ caused a 1.4-fold lower affinity for Ca2+. These experiments strongly suggest that cytosolic free Mg2+ occupies a significant population of the available site II. Interaction of Mg2+ with site II of cTnC likely has important functional consequences for the heart both at baseline as well as in diseased states which decrease or increase the availability of Mg2+ such as secondary hyperparathyroidism or ischemia, respectively.

1 August 2020 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
YSYu Patrick Shi
Yu Patrick Shi
ZPZhaoKai Pang
ZhaoKai Pang
RVRavichandra Venkateshappa
Ravichandra Venkateshappa
MGMarvin Gunawan
Marvin Gunawan
JKJacob Kemp
Jacob Kemp
TCThomas W. Claydon
Thomas W. Claydon
Human ether-à-go-go related gene (hERG) K+ channels are important in cardiac repolarization, and their dysfunction causes prolongation of the ventricular action potential, long QT syndrome, and arrhythmia. As such, approaches to augment hERG channel function, such as activator compounds, have been of significant interest due to their marked therapeutic potential. Activator compounds that hinder channel inactivation abbreviate action potential duration (APD) but carry risk of overcorrection leading to short QT syndrome. Enhanced risk by overcorrection of the APD may be tempered by activator-induced increased refractoriness; however, investigation of the cumulative effect of hERG activator compounds on the balance of these effects in whole organ systems is lacking. Here, we have investigated the antiarrhythmic capability of a hERG activator, RPR260243, which primarily augments channel function by slowing deactivation kinetics in ex vivo zebrafish whole hearts. We show that RPR260243 abbreviates the ventricular APD, reduces triangulation, and steepens the slope of the electrical restitution curve. In addition, RPR260243 increases the post-repolarization refractory period. We provide evidence that this latter effect arises from RPR260243-induced enhancement of hERG channel-protective currents flowing early in the refractory period. Finally, the cumulative effect of RPR260243 on arrhythmogenicity in whole organ zebrafish hearts is demonstrated by the restoration of normal rhythm in hearts presenting dofetilide-induced arrhythmia. These findings in a whole organ model demonstrate the antiarrhythmic benefit of hERG activator compounds that modify both APD and refractoriness. Furthermore, our results demonstrate that targeted slowing of hERG channel deactivation and enhancement of protective currents may provide an effective antiarrhythmic approach. NEW & NOTEWORTHY hERG channel dysfunction causes long QT syndrome and arrhythmia. Activator compounds have been of significant interest due to their therapeutic potential. We used the whole organ zebrafish heart model to demonstrate the antiarrhythmic benefit of the hERG activator, RPR260243. The activator abbreviated APD and increased refractoriness, the combined effect of which rescued induced ventricular arrhythmia. Our findings show that the targeted slowing of hERG channel deactivation and enhancement of protective currents caused by the RPR260243 activator may provide an effective antiarrhythmic approach.

20 August 2020 in The Canadian Journal of Psychiatry
Verified
Journal Article
Closed access
PDF file
YYYue Bo Yang
Yue Bo Yang
PCPeter Chan
Peter Chan
KRKaveh Rayani
Kaveh Rayani
AMAlexander McGirr
Alexander McGirr

22 September 2022 in European Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
KRKaveh Rayani
Kaveh Rayani
BDBrianna Davies
Brianna Davies
MCMatthew Cheung
Matthew Cheung
DCDrake Comber
Drake Comber
JRJason D. Roberts
Jason D. Roberts
ZLZachary Laksman
Zachary Laksman

15 June 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
KRKaveh Rayani
Kaveh Rayani
JSJ T Seffernick
J T Seffernick
YLYueh Alison Li
Yueh Alison Li
JDJonathan P Davis
Jonathan P Davis
ASAnne Spuches
Anne Spuches
GTGlen Findlay Tibbits
Glen Findlay Tibbits
Cardiac troponin C (cTnC) is the Ca 2+ -sensing component of the thin filament. It contains structural sites (III/IV) which bind both Ca 2+ and Mg 2+ , and a regulatory site (II) that has been thought to bind only Ca 2+ . The latter binding initiates a series of conformational changes that culminate in force production. We have quantified the interaction between site II and Ca 2+ /Mg 2+ through Isothermal Titration Calorimetry and Thermodynamic Integration simulations. Direct and competitive binding titrations using wild type and a double mutant that significantly reduces binding to site II demonstrated that physiologically relevant concentrations of both Ca 2+ /Mg 2+ interact with the same locus. Cytosolic free Mg 2+ (~1 mM) could occupy a significant population of available site II, as this concentration of Mg 2+ decreased the affinity for Ca 2+ 1.4-fold. Interaction of Mg 2+ with site II of cTnC likely has important functional consequences for the heart at baseline and in diseased states which decrease or increase availability of Mg 2+ such as secondary hyperparathyroidism or ischemia, respectively.